Introduction
Surgical restoration of the left ventricular wall (Dor procedure) has been advocated as a therapy for left ventricular dysfunction due to ischemic cardiomyopathy. This procedure involves placement of an endoventricular patch through a ventriculotomy.
Methods
We reviewed our series of patients that underwent the Dor procedure within the past 4 years and examined their pre and postoperative ventricular function and mitral valve function. Pre and postoperative ejection fraction and degree of mitral regurgitation were analyzed using the paired Student t-test. We hypothesized that this procedure would result in improved ventricular function and that it would also help improve mitral valve function.
Results
Thirty-four patients underwent this procedure, with one death. Of these, 30 patients underwent concomitant coronary artery bypass grafting and 8 patients had mitral intervention (seven had an Alfieri repair of the mitral valve, and one had mitral valve annuloplasty). The average preoperative ejection fraction among these patients was 26.8% (range 10 -45%). The postoperative ejection fraction was significantly higher at 35.4% (range 25-52%) (P Ͻ .001). We noted an improvement in ejection fraction in 27 patients (82%). We also noted that 21 of 33 patients (64%) had improvement in the degree of mitral regurgitation based on echocardiography data (P Ͻ .001).
Conclusions
We conclude that the Dor procedure results in improvement in the left ventricular function. Furthermore, we also note that this procedure ameliorates mitral regurgitation in a majority of these patients even in the absence of associated mitral valve procedures, probably due to reduction in the size of the ventricle and improved orientation of the papillary muscles.
Myocardial ischemia resulting in ischemic cardiomyopathy remains a perplexing surgical problem to treat. Cardiomyopathy resulting from ischemia of the left anterior descending coronary artery resulting in ventricular scarring represents a unique challenge for the cardiovascular surgeon. Ischemic cardiomyopathy results in a ventricle that is scarred or dilated, resulting in an inefficient pumping cham-ber. 1 Various surgical modalities have been utilized in the treatment of the ischemic cardiomyopathy. Coronary artery bypass grafting 2 with or without valve replacement 3 and, in severe cases, heart transplantation 4 have been utilized for dilated cardiomyopathy. Surgical remodeling of the ventricle has been utilized in the past decade. One technique of surgical remodeling consisted of left ventriculectomy, during which a portion of the dilated left ventricle is removed. 5 This technique proposed by Batista has since fallen out of favor because of the poor long-term outcome. 6 Surgical restoration of left ventricular wall has been proposed as a technique for the treatment of left ventricular aneurysms. A endoventricular patch technique for left ventricular aneurysms was proposed by Vincent Dor for the surgical resto-ration of the left ventricular anatomy. 7 The Dor procedure has since been proposed as an alternative treatment for ischemic cardiomyopathy even in the absence of left ventricular aneurysm. The procedure entails the placement of an endoventricular patch to exclude the dilated area of the left ventricle. We hypothesized that the Dor procedure will result in improved left ventricular function in patients with ischemia cardiomyopathy an enlarged left ventricle. We also believe that the alteration in ventricular geometry secondary to the Dor procedure will result in reduced degree of mitral regurgitation.
METHODS
We undertook a retrospective review all patients that underwent the Dor procedure at our institution from 1998 to 2001. Institutional review board approval was obtained before conducting this chart review. Patient data including age, sex, preoperative diagnosis, pre, and postoperative echocardiogram with ventricular function and degree of mitral insufficiency, operative procedure, and postoperative course were reviewed.
We have described the technical aspects in the past 8 ; briefly, it is as follows: Intraoperative transesophageal echocardiography was utilized before cardioplegic arrest to evaluate the ventricular function and mitral valve function. Patients received anterograde and frequently retrograde blood cardioplegia. All but four patients underwent coronary artery bypass grafting. Internal thoracic artery was utilized for grafting in all patients and the Dor procedure was performed before performing the proximal anastomoses in most of the patients. With the aortic crossclamp in place, the ventricle was opened near the apex, frequently in an ecchymotic area that is usually scarred and thin. The ventriculotomy was then extended to visualize the interior of the left ventricular chamber. A Fontan stitch of 2 to 0 prolene was then used to create a ridge to anchor the patch, and to reduce the ventricular diameter. This stitch was situated at the base of the papillary muscles, with the belief that this would stabilize these structures and decrease preoperative mitral regurgitation. In the subset of patients who demonstrated severe preoperative mitral regurgitation, we performed the Alfieri repair of the mitral valve. The Alfieri repair involves the placement of a figure of eight stitch in the middle of the posterior and anterior leaflets, thus bringing them together in the center. A Dacron patch (DuPont, Wilmington, DE) is then sewn to the ridge created by the Fontan stitch, thereby completing the ventricular remodeling. The ventriculotomy is then closed and the patient is weaned from cardiopulmonary bypass after completion of the proximal anastamoses. Five patients required placement of intraaortic balloon pump to aid the weaning process. All patients underwent a postoperative TEE to examine the ventricle and mitral valve function after the procedure. One patient who underwent the Alfieri repair of the mitral valve continued to exhibit severe mitral regurgitation. This patient was then placed back on cardiopulmonary bypass and a mitral valve annuloplasty was performed. The patient had an uneventful recovery. We had one patient die after the Dor procedure.
The patient data were then collated and statistical analysis was utilized to determine differences between the pre and postoperative ventricular function and degree of mitral insufficiency. Student t-test was used to determine the P-value.
RESULTS
There were a total of 34 patients with ischemic cardiomyopathy who underwent the Dor procedure. The mean age of the patients was 61.9 years. There were a total of 24 male and 8 female patients. Of these patients, 30 underwent concomitant coronary artery bypass grafting. There was one death. Eight patients underwent concomitant mitral intervention. Of these, seven patients had an Alfieri repair of the mitral valve and one patient underwent a mitral valve annuloplasty after a failed Alfieri repair. There have been no late deaths.
Ventricular Function
We evaluated the ventricular function based on the echocardiographic results and the ventriculogram. The postoperative ejection fraction was estimated based on the echocardiogram. The average preoperative ejection fraction was 26.8% (range 10 -45%). The average postoperative ejection fraction was 35.4% (range 25-52%). We noted that 27 of 33 patients (82%) who survived the operation had an increase in their ejection fraction after the procedure. The increase in ejection fraction was a statistically significant finding (P Ͻ .001).
Mitral Insufficiency
The degree of mitral insufficiency was graded based on the pre and postoperative echocardiographic findings. We analyzed the degree of mitral insufficiency in the 33 patients who survived the surgery. Twenty-one (64%) of these patients had a demonstrable improvement in the degree of mitral insufficiency. Among the seven patients that underwent the Alfieri mitral valve repair, six had improvement in their mitral insufficiency (86%). We also noted improvement in the mitral insufficiency among 15 of the 25 patients (60%) that did not have any mitral intervention. This improvement in the mitral insufficiency was a statistically significant finding (P Ͻ .001).
DISCUSSION
The treatment of ischemic cardiomyopathy has evolved over the past decades. Ischemic cardiomyopathy represents a significant number of patients with heart failure. Unlike patients with other forms of cardiomyopathy, medical management has been found to be ineffective in this patient Ventricular Reconstruction Results population. Various surgical modalities have been proposed over the past few decades for the treatment of this entity. The traditional treatment for this disease process included coronary artery bypass grafting if there is viable myocardium, 9 and mitral valve replacement if there is a component of mitral insufficiency. We have shown in the past that patients with ischemic cardiomyopathy can undergo coronary artery bypass or mitral valve replacement safely. 2, 3 Heart transplantation has evolved as the treatment for ischemic cardiomyopathy refractory to the above surgical strategy 4 but donor shortage and cost are the major issues. Several new ventricular remodeling procedures have been proposed for the treatment of the dilated ventricle secondary to ischemia. Batista proposed a procedure that involves resection of a piece of the left ventricular wall, theoretically making the ventricle a more efficient chamber. 5 This procedure is based on Laplace's law, which states that the pressure generated in the ventricle is directly proportional to the radius of the ventricle. Theoretically, reduction in the radius of the ventricle should result in less transmural pressure being generated and make the ventricle a more efficient chamber. However, in long-term studies the efficacy of this procedure has been disputed, except for the subset of patients with idiopathic cardiomyopathy who are poor candidates for heart transplantation. 6 The newer surgical modalities for cardiomyopathy have benefited from the lessons learned in the treatment of left ventricular aneurysms. The endoventricular repair as described by Dor involves the placement of an endoventricular Dacron patch through a ventriculotomy. The long-term results 7 of patients that have undergone the Dor procedure for left ventricular aneurysms had led us to believe that this procedure could be a safe and effective procedure for ischemic cardiomyopathy. The procedure, we believe, works especially well in patients with poor ventricles who were traditionally thought to be poor candidates for myocardial revascularization alone due to the size of their ventricle.
We believe that the amelioration of mitral insufficiency after the Dor procedure is related to the reshaped ventricle. Restoration of the left ventricular geometry results in a narrower configuration of papillary muscles with an improvement in the degree of mitral insufficiency. However, the long-term effects of this reshaped geometry and the realignment of the mitral apparatus need to be elucidated.
We also believe that the Dor procedure, along with coronary artery bypass surgery, represents a substantial cost saving in surgery for ischemic cardiomyopathy. We recently published a study examining the various surgical modalities for heart failure. 10 This study compares the cost and survival among patients that have undergone heart transplantation, isolated coronary artery bypass grafting, mitral valve replacement, and Dor procedure. We noted that the total cost of heart transplantation, which includes the procurement costs, was significantly higher among the heart transplant group. The cost was comparable among the other three groups. The operative survival was comparable among the four groups. Alternative surgical operations for ischemic cardiomyopathy such as the Dor procedure represent a viable option for the select patients.
Our results mirror those reported by others over the past few years. Athanasuleas et al. reported a series of 12 patients that had undergone the Dor procedure for postinfarct apical akinesis. 11 They noted that the ejection fraction improved from 20 to 35%. Furthermore, they noted a decrease in the both the left ventricular end systolic volume index and diastolic volume index by 39% and 29%, respectively. Another study by Cherniavsky et al. 12 reviewed their series of 41 patients that underwent ventricular remodeling. They noted an increase in the EF from 38% to 49%. They point out the importance of preoperative ventricular modeling to determine the extent of surgical remodeling. Doenst et al. 13 echoed similar results, noting an improvement in the cardiac function after the Dor procedure. However, they point out the lack of long-term studies in patients that have undergone this procedure for ischemic cardiomyopathy, and they currently advocate it only for patients with contraindications for heart transplantation. Beyersdorf et al. have recently published their technique for performing the Dor procedure on the beating heart, 14 thus decreasing the need for mechanical assistance in this sick population. We believe that with the advent of newer techniques, the Dor ventricular restoration procedure will evolve as a safe and durable procedure for a growing number of patients with ischemic cardiomyopathy. Congestive heart failure is the primary hospital discharge diagnosis in patients who are 65 years of age and older. As our population continues to age, many therapies will be used to treat these patients. As the authors point out, these include better medication regiments, better pacemaker technology, transplantation, and the insertion of artificial devices. The Dor procedure will certainly have a place in the surgical management of these patients.
I have a few questions. In a recent review of 44 patients from Dor's institution, he reported similar improvement in systolic function but a worsening of preoperative mitral regurgitation and a significant incidence of new postoperative mitral regurgitation in these patients. Are these findings related to the imaging techniques used in identifying mitral regurgitation? Or is there a difference in surgical technique? Was the improvement in LV function due to a decrease in the end diastolic volume index or an increase in the stroke volume index? Did you observe in your echocardiographic data a change in left ventricular geometry as Dr. Kaza pointed out in his discussion?
Finally, what are the preoperative criteria that you use to decide which patients should undergo mitral valve repair concomitant with the Dor procedure?
Dr. Kaza did a great job with the presentation of these outstanding data and I thank the Association for the privilege of discussing it. DR. W. RANDOLPH CHITWOOD, JR. (Greenville, North Carolina): I would like to compliment Dr. Kaza on a fine presentation and thank him for providing his manuscript to me before this meeting. Dr. Kron's group is to be congratulated for presenting new and evolving information in this area, especially regarding the surgical treatment of severely impaired left ventricles from coronary artery disease. To improve cardiac efficiency in patients with either ventricular aneurysms or severe dyskinesia, Dr. Cooley first suggested resection and a linear defect closure in 1959. More recently, hopes for additionally improving myocardial function in these patients and in those with ventricular akinesia were predicated on resuscitating impaired myocardium through coronary revascularization. However, in many instances, congestive heart failure was not abated. In 1984, Jatene, Cooley, and Dor, working independently and using entirely different surgical methods, first determined that better cardiac efficiency could be obtained in severely akinetic ventricles by excluding the entire thinly scarred intraventricular region, including the free wall and septum. More recently, the work of Dor and associates, as well as Mickleborough, have helped define the mechanism of this improvement that you have seen today. Ventricular function is predicated on complex interrelating factors and structures, including myocardial blood supply and energy demands, ventricular chamber size and geometry, myocardial contractile element orientation, aortic and mitral valvular function, and papillary muscle chordal axes. Each of these factors is altered in the dilated, ischemically impaired left ventricle. Functional improvement is predicated on alteration of abnormalities in each of these factors.
Dr. Kaza has shown nicely that these impaired ventricles can be revascularized and reengineered safely using the endoventricular patch method of Dor. The University of Virginia Group had only one death in 34 patients. Moreover, ejection fractions improved by approximately 10% in 82% of these patients. Comparatively, the recent RESTORE trial of 439 patients had greater mortality at 6% and similar ventricular function improvements.
In the UVA series presented, surgeons combined a mitral edge-to-edge approximation method, the Alfieri technique, with the Dor procedure in seven patients. Alternatively, 25 patients had no concomitant mitral procedure. It is very, very interesting that in these 15 patients, mitral valve regurgitation improved significantly, and presumably from ventricular reconstruction alone. I think that this is the new major information in this paper and relates to these 15 patients. We know that both the ischemic region and a spherical dilated ventricle can induce type III restrictive mitral insufficiency. Generally, patients with severe akinesia from anterior infarctions with septal involvement result in an ellipsoid geometry with lateral papillary muscle displacement. Related systolic chordal tethering causes the mitral regurgitation.
You have suggested in your paper that the reduction in mitral insufficiency results primarily from reducing the border zone minor-axis link by the Fontan stitch, and aligning the papillaries more perpendicular to the mitral leaflet edges during systole. Dr. Kron, what part could either concomitant coronary revascularization or the intraventricular patch itself play in improving this regurgitation?
Many of Dor's patients with greater spheriosity and increased LV volumes ultimately developed mitral insufficiency within 1 year. Are you concerned about your series and the ultimate development of mitral insufficiency? Should we always add a valve procedure based on those data, as you did in a number of patients?
Denato and Dor also showed an inverse relationship between left ventricular end systolic volume index and ejection fraction. Dr. Kron, do you believe that ventricular function improvement in your patients resulted singularly from chamber remodeling with a decrease in end-systolic volume? Or was it also affected by the more physiologic reorientation of the contractile elements in the improved coronary perfusion?
Dor has shown that preoperative patients with the largest end-diastolic diameters and/or severe mitral regurgitation have not done well in the long term. Did you make comparisons regarding the midterm survival of these patients in your group, Dr. Kron and Dr. Kaza? In Dr. Mickleborough and Dr. Dor's earlier series, most of their patients had previous anterior myocardial infarctions.
Moreover, they suggested that individuals with inferior infarctions did not do well after ventricular remodeling. Your manuscript did not describe the regional locations of akinesia in your patients. Did most of these patients have anterior involvement and did you include patients with right-sided infarctions? How would you compare your patient cohort to those who have dilated symmetric ischemic cardiomyopathies and coronary disease versus localized disease in your group? I think this is an important and a fascinating study -a very interesting area for young surgeons to study. I believe that the detailed analysis of long-term results will prove that there are variable survival populations. Moreover, myocardial cell restoration therapy and genetic ventricular remodeling eventually may be adjunctive to the positive results shown here today by Dr. Kron's group. Surgeons must be the ones to bring forth the structural and tissue engineering answers for this important problem.
DR. IRVING L. KRON (Charlottesville, Virginia): I would like to thank Drs. Baumgartner and Chitwood for their thoughtful questions. When we first got into this procedure we didn't believe at all that this could add anything to just coronary bypass alone. We found in the long run our large ventricles did worse, and we hoped that the procedure would make a difference. 
Ventricular Reconstruction Results
Dr. Baumgartner asked why less mitral regurgitation as compared another series. We believe it is a difference due to a change in technique. We think it is critically important that you make the neck -you are sort of creating an aneurysm, if you would, with this Fontan stitch. And if you make that neck at the base of the papillary muscles, I think you will hold the shape of the papillary muscles better and have better orientation.
Why the improvement in ejection fraction? Both Dr. Chitwood and Dr. Baumgartner asked this. We feel it is due to both reduced left ventricular end diastolic volume index, as well as improvement in regional wall motion and possible geometry. Of course, you have the coronary bypass that improves your regional wall motion, but we think you have to make these ventricles smaller. We have looked at a comparative series of large ventricles that had coronary bypass alone, and their EF only goes up 2-3%. The truth is that with that they don't get a whole lot better.
When do we add a mitral repair? We no longer do the Alfieri repair. We found it to be inconsistent, as Dr. Kaza mentioned to you. If we see three plus MR ahead of time, it really doesn't matter to us what the echo shows in the operating room because that is all based on loading conditions and the level of anesthesia. They will get a standard mitral repair through a left atriotomy. These days we think you really have to deal with the subvalvular apparatus as well because, as Dr. Chitwood had mentioned, this causes a leaflet tethering. The tethering doesn't get better unless you deal with it.
Therefore, we try to reef up the posterior papillary muscle, which, of course, has cords to both the posterior and anterior leaflets.
Dr. Chitwood asked if coronary bypass alone improves mitral regurgitation. Certainly in the acutely ischemic situation, it does. We know that if you have global ischemia, it really doesn't matter much what happens to papillary muscles. The ventricle dilates and the mitral regurgitation gets worse. These were mostly, except for the six acute patients, essentially chronic MRs when we dealt with them, so we think most of the issue here was realignment of the geometry.
What about midterm survival? Good question. We had one late death and therefore, so far so good. However, the series is only 3 years old. The majority of cases have been done in the last year and a half.
What about inferior infarcts; do they do worse? We believe you need an anterior infarction as part of this to do the operation. Now, in most of these patients, you don't get a low EF from just the anterior infarct alone. They have had infarctions both to anterior and inferior walls. So we don't think that prevents you from doing the operation. But we would hate to go through good anterior wall to deal with an inferior problem.
So right now we believe that the indications are in patients who have large ventricles, coronaries we can do something with, and at least an anterior infarct as part of their presentation.
